Skip to main content
Premium Trial:

Request an Annual Quote

All Personal

The drug pipelines of pharmaceutical companies like AstraZeneca are full of therapeutics being developed for personalized medicine, writes Frank Vinluan at MedCity News. AstraZeneca's Steve Labkoff says that 65 percent of the company's pipeline is personalized medicine. Vinluan adds that a common theme at the SAS Health Care and Life Sciences Executive Conference last week, where Labkoff was a speaker, was that "big data healthcare information is on its way to consumers" and that it will extend beyond medicine to insurance.

"Analysis of patient data from [Blue Cross Blue Shield North Carolina] will enable the company to develop plans tailored to customers," Vinluan writes, adding that big data is "already helping to develop pharmaceuticals personalized to patients. And soon their healthcare plans will become personalized, too."

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.